| 19.01.2011 Opalesque Exclusive: SunGard reports growth in OTC valuation business for Ucits |
| By Beverly Chandler, Opalesque UK: The increasing strength of the ‘gold standard’ Ucits product and the implications of the arrival of AIFM have led to a growth in the number of fund managers seeking independent valuations of the OTC derivatives parts of their portfolios. “The newest Ucits framework, Ucits IV, provides some scope for asset managers to use derivatives to a greater exte |
| Article source: http://www.SunGard.com/en/sitecore/content/campaigns/fs/alternativeinvestments/fastval/resources/fastvalucitswhitepaper.aspx - Opalesque is not responsible for the content of external internet sites |